2020
DOI: 10.1007/s13555-020-00468-7
|View full text |Cite
|
Sign up to set email alerts
|

Menopause and the Skin: Old Favorites and New Innovations in Cosmeceuticals for Estrogen-Deficient Skin

Abstract: Estrogen is a pivotal signaling molecule; its production is regulated by the expression of the aromatase (CYP19A1) gene from ovarian and peripheral tissue sites, and it is transmitted via estrogen receptors to influence many important biological functions. However, the narrative for this overview focuses on the decline of 17bestradiol levels from ovarian sites after menopause. This estrogen-deficient condition is associated with a dramatic reduction in skin health and wellness by negatively impacting dermal ce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
123
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 63 publications
(184 citation statements)
references
References 90 publications
0
123
0
3
Order By: Relevance
“…As noted, there were no significant differences in the levels of apoptotic cells among the treatments at just above 10%. Finally, telomere shortening apparently limits the cellular doubling capacity, at least in human cells and a clinical study examining topical equol administration showed a significant increase in telomere length, skin texture, smoothness, firmness, and elasticity [18], which may also support the anti-aging effects of equol, especially in estrogen-deficient skin, as reported in another clinical study [12]. Notably, both clinical studies examining equol's topical effects on dermal parameters were performed independently of our (Lephart) laboratory.…”
Section: Discussionmentioning
confidence: 58%
See 3 more Smart Citations
“…As noted, there were no significant differences in the levels of apoptotic cells among the treatments at just above 10%. Finally, telomere shortening apparently limits the cellular doubling capacity, at least in human cells and a clinical study examining topical equol administration showed a significant increase in telomere length, skin texture, smoothness, firmness, and elasticity [18], which may also support the anti-aging effects of equol, especially in estrogen-deficient skin, as reported in another clinical study [12]. Notably, both clinical studies examining equol's topical effects on dermal parameters were performed independently of our (Lephart) laboratory.…”
Section: Discussionmentioning
confidence: 58%
“…For example, a few notable polyphenolic compounds include the stilbene (resveratrol), the flavonoid (quercetin), and the isoflavonoid (equol), where the use of equol in cosmetics has been relatively recent compared to other polyphenols. However, beneficial skin properties of equol have been reported in various in vitro and clinical studies [4,5,12,18] and, in fact, equol was reported to have significantly greater efficacy compared to astaxanthin for antioxidants, extracellular matrix integrity, growth factors, and inflammatory biomarkers via human skin gene expression analysis [19]. Therefore, the purpose of the present study was to confirm and extend the data base in understanding the skin-related properties of equol by in vitro techniques and point out the potential challenges associated with cell/tissue culture conditions in this examination.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…We previously confirmed that with RSV treatment, the thymus could recover from the alterations caused by d-gal intake via the promotion of autoimmune regulator (Aire) expression (Wei et al, 2020). RSV even inhibits skin aging through estrogen (Lephart & Naftolin, 2021).…”
Section: Discussionmentioning
confidence: 62%